Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289

Probiotic strains intended for use in the oral cavity and upper respiratory tract are exposed to substantially higher oxygen levels than strains targeting the intestinal environment. We hypothesised that continuous oxygen exposure of an established probiotic strain used under conditions of high oxidative pressure, namely Limosilactobacillus reuteri ATCC PTA 5289 (Lr5289), would enable the natural selection of a variant better adapted to such an environment. Using this approach, the novel strain L. reuteri BG-R33® (DSM 33633) was obtained and demonstrated improved tolerance to an oxygen-rich environment. Interestingly, the strain also exhibited increased tolerance to hydrogen peroxide, a frequent challenge in the oral environment. In addition, compared to its progenitor, the novel strain showed a slightly improved capacity to inhibit the oral pathogen Streptococcus mutans and enterotoxigenic Escherichia coli, mainly through production of the antimicrobial metabolite reuterin. Tolerance to gastrointestinal stressors was also evaluated, and BG-R33® displayed increased bile tolerance compared with Lr5289, whereas tolerance to low pH (2.0) and adhesion to mucus and saliva did not differ between the strains. Both the genotype and phenotype of the novel strain were shown to be stable. Finally, BG-R33® was characterised in direct comparison with Lr5289 and exhibited a similar genomic and phenotypic safety profile, with no concerns identified. These subtle but distinct differences between the strains provide a rationale for further investigation of L. reuteri BG-R33® for applications targeting disorders of the oral cavity and upper respiratory tract.

Authors

Institutions

Publication Details

Journal
Journal of Industrial Microbiology & Biotechnology
Published
2026-11-16
DOI
https://doi.org/10.1093/jimb/kuag030
Primary Topic
Probiotics and Fermented Foods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289

Gianfranco Grompone, Stefan Roos, Ludwig Ermann Lundberg, Sebastian Håkansson et al.
Journal of Industrial Microbiology & Biotechnology
Probiotics and Fermented Foods
article

Characterisation of Limosilactobacillus reuteri BG-R33®, an evolved aerotolerant derivative of the probiotic strain ATCC PTA 5289

Gianfranco Grompone, Stefan Roos, Ludwig Ermann Lundberg, Sebastian Håkansson, Punya Pallabi Mishra, Peidi Liu, Malin Sendelius, Jakob Axelsson
article en

Abstract

Probiotic strains intended for use in the oral cavity and upper respiratory tract are exposed to substantially higher oxygen levels than strains targeting the intestinal environment. We hypothesised that continuous oxygen exposure of an established probiotic strain used under conditions of high oxidative pressure, namely Limosilactobacillus reuteri ATCC PTA 5289 (Lr5289), would enable the natural selection of a variant better adapted to such an environment. Using this approach, the novel strain L. reuteri BG-R33® (DSM 33633) was obtained and demonstrated improved tolerance to an oxygen-rich environment. Interestingly, the strain also exhibited increased tolerance to hydrogen peroxide, a frequent challenge in the oral environment. In addition, compared to its progenitor, the novel strain showed a slightly improved capacity to inhibit the oral pathogen Streptococcus mutans and enterotoxigenic Escherichia coli, mainly through production of the antimicrobial metabolite reuterin. Tolerance to gastrointestinal stressors was also evaluated, and BG-R33® displayed increased bile tolerance compared with Lr5289, whereas tolerance to low pH (2.0) and adhesion to mucus and saliva did not differ between the strains. Both the genotype and phenotype of the novel strain were shown to be stable. Finally, BG-R33® was characterised in direct comparison with Lr5289 and exhibited a similar genomic and phenotypic safety profile, with no concerns identified. These subtle but distinct differences between the strains provide a rationale for further investigation of L. reuteri BG-R33® for applications targeting disorders of the oral cavity and upper respiratory tract.

Journal of Industrial Microbiology & Biotechnology
Lund University (SE), Swedish University of Agricultural Sciences (SE), BioGaia (Sweden) (SE), Wallenberg Wood Science Center (SE), University of Gothenburg (SE)
Probiotics and Fermented Foods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon